妇科恶性肿瘤的预防方法。
Approaches to prevention of gynecological malignancies.
作者信息
Ferrari Federico, Giannini Andrea
机构信息
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Unit of Gynecology, Department of Surgical and Medical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
出版信息
BMC Womens Health. 2024 Apr 23;24(1):254. doi: 10.1186/s12905-024-03100-4.
Abstract
Gynecological malignancies represent one of the prevalent diseases in the female sex and prevention is essential to limit their incidence and mortality. Nowadays, not all malignancies benefit from adequate screening methods for this reason new biomarkers and methods are being developed to undertake timely and effective therapies.
摘要
妇科恶性肿瘤是女性常见疾病之一，预防对于限制其发病率和死亡率至关重要。如今，并非所有恶性肿瘤都能从充分的筛查方法中获益，因此正在开发新的生物标志物和方法以进行及时有效的治疗。
相似文献
1
Approaches to prevention of gynecological malignancies.
BMC Womens Health. 2024 Apr 23;24(1):254. doi: 10.1186/s12905-024-03100-4.
2
Gynecologic Cancer Screening and Prevention: State of the Science and Practice.
Curr Treat Options Oncol. 2025 Mar;26(3):167-178. doi: 10.1007/s11864-025-01301-z. Epub 2025 Feb 27.
3
Prevention and early detection of cancer.
Gynecol Oncol. 2011 Apr;121(1):1. doi: 10.1016/j.ygyno.2011.02.009.
4
Determining the knowledge of women and their attitudes regarding gynecological cancer prevention.
Asian Pac J Cancer Prev. 2013;14(10):6055-9. doi: 10.7314/apjcp.2013.14.10.6055.
5
Clinical aspects of gynecological cancers' prophylaxis.
J BUON. 2006 Oct-Dec;11(4):439-45.
6
Knowledge and health care-seeking behavior in relation to gynecological malignancies in India: a study of the patients with gynecological malignancies in a tertiary care hospital of Kolkata.
J Cancer Educ. 2011 Jun;26(2):348-54. doi: 10.1007/s13187-010-0168-9.
7
Strategies for the modification of risk factors in gynecological cancers.
Eur J Gynaecol Oncol. 2002;23(1):5-10.
8
[The oncological screening of diseases of gynecological and urological profile as one of measures preventing reproductive health: A review].
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024 Nov;32(6):1249-1253. doi: 10.32687/0869-866X-2024-32-6-1249-1253.
9
Preventing Global Human Papillomavirus-Associated Lower Genital Disease.
J Low Genit Tract Dis. 2018 Oct;22(4):267-268. doi: 10.1097/LGT.0000000000000427.
10
Botanical medicines with gynecological anticancer activity: a literature review.
J Am Med Womens Assoc (1972). 1999 Fall;54(4):184-90,195.
引用本文的文献
1
From Bench to Bedside in Emerging Therapies for Gynecological Malignancies: A Narrative Review.
Cancer Control. 2025 Jan-Dec;32:10732748251357158. doi: 10.1177/10732748251357158. Epub 2025 Jul 6.
2
MiR-484 Regulates the IL-6/STAT3 Signaling Pathway by Down-Regulating KLF12 to Inhibit the Malignant Progression of Cervical Cancer.
Int J Womens Health. 2025 Apr 26;17:1165-1174. doi: 10.2147/IJWH.S491749. eCollection 2025.
3
Predictive value of models based on MRI radiomics and clinical indicators for lymphovascular space invasion in endometrial cancer.
BMC Cancer. 2025 Apr 28;25(1):796. doi: 10.1186/s12885-025-14217-6.
4
Multi-Omics Analysis Revealed That TAOK1 Can Be Used as a Prognostic Marker and Target in a Variety of Tumors, Especially in Cervical Cancer.
Onco Targets Ther. 2025 Mar 14;18:335-353. doi: 10.2147/OTT.S506582. eCollection 2025.
5
A meta-analysis of albumin, globulin, and albumin globulin ratios for predicting prognosis of cervical cancer.
Eur J Cancer Prev. 2025 Jul 1;34(4):337-348. doi: 10.1097/CEJ.0000000000000958. Epub 2025 Feb 27.
6
Role of the collagen scaffold in preventing intrauterine adhesion from recurrence after adhesiolysis: protocol for a multicentre, randomised, controlled, parallel-group, open-label, superiority clinical trial.
BMJ Open. 2025 Feb 26;15(2):e091299. doi: 10.1136/bmjopen-2024-091299.
7
regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses.
Transl Cancer Res. 2025 Jan 31;14(1):354-370. doi: 10.21037/tcr-24-949. Epub 2025 Jan 23.
8
Significance of Gelsolin Superfamily Genes in Diagnosis, Prognosis and Immune Microenvironment Regulation for Endometrial Cancer.
Cancer Med. 2025 Feb;14(4):e70584. doi: 10.1002/cam4.70584.
9
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Front Immunol. 2025 Jan 30;16:1528084. doi: 10.3389/fimmu.2025.1528084. eCollection 2025.
10
Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis.
Front Immunol. 2025 Jan 20;15:1528957. doi: 10.3389/fimmu.2024.1528957. eCollection 2024.
本文引用的文献
1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Endometrial Carcinomas with Intestinal-Type Metaplasia/Differentiation: Does Mismatch Repair System Defects Matter? Case Report and Systematic Review of the Literature.
J Clin Med. 2020 Aug 6;9(8):2552. doi: 10.3390/jcm9082552.
3
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
J Ovarian Res. 2019 Mar 27;12(1):28. doi: 10.1186/s13048-019-0503-7.
4
Prevention Strategies in Endometrial Carcinoma.
Curr Oncol Rep. 2018 Nov 13;20(12):101. doi: 10.1007/s11912-018-0747-1.
5
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
6
HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):393-9. doi: 10.1158/1055-9965.EPI-14-0649. Epub 2014 Nov 21.
7
Diagnostic strategies for postmenopausal bleeding.
Obstet Gynecol Int. 2010;2010:850812. doi: 10.1155/2010/850812. Epub 2010 Feb 4.
8
Weight change and risk of endometrial cancer.
Int J Epidemiol. 2006 Feb;35(1):151-8. doi: 10.1093/ije/dyi226. Epub 2005 Nov 8.
9
Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study.
J Natl Cancer Inst. 2004 Nov 3;96(21):1635-8. doi: 10.1093/jnci/djh291.
Zotero 插件